Production (Stage)
Amedisys, Inc.
AMED
$93.43
-$0.13-0.14%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 89.84M | 43.23M | 82.93M | 91.98M | -20.59M |
| Total Depreciation and Amortization | 61.19M | 60.46M | 59.31M | 58.38M | 58.03M |
| Total Amortization of Deferred Charges | 991.00K | 991.00K | 991.00K | 991.00K | 991.00K |
| Total Other Non-Cash Items | 37.18M | 77.09M | 41.54M | 49.89M | 151.96M |
| Change in Net Operating Assets | 35.31M | 39.90M | 26.92M | -105.00M | -85.70M |
| Cash from Operations | 224.52M | 221.67M | 211.70M | 96.23M | 104.69M |
| Capital Expenditure | -5.10M | -6.55M | -7.33M | -6.93M | -6.94M |
| Sale of Property, Plant, and Equipment | 15.00K | -- | 36.00K | 36.00K | 136.00K |
| Cash Acquisitions | -- | -- | 0.00 | 0.00 | 0.00 |
| Divestitures | -- | -- | 0.00 | 0.00 | 0.00 |
| Other Investing Activities | -1.59M | -1.81M | -1.83M | -831.00K | -7.10M |
| Cash from Investing | -6.67M | -8.36M | -9.12M | -7.73M | -13.90M |
| Total Debt Issued | -- | -- | 0.00 | 0.00 | 15.00M |
| Total Debt Repaid | -38.16M | -37.36M | -36.63M | -33.40M | -44.64M |
| Issuance of Common Stock | 402.00K | 309.00K | 88.00K | 873.00K | 1.89M |
| Repurchase of Common Stock | -8.40M | -6.15M | -6.96M | -7.24M | -5.84M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -7.52M | -5.72M | -7.64M | -2.54M | -5.59M |
| Cash from Financing | -53.67M | -48.92M | -51.14M | -42.31M | -39.18M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 164.18M | 164.38M | 151.43M | 46.20M | 51.60M |